Mathias Karlsson, BS

About Mathias Karlsson

Mathias is a Swedish medical student starting his medical studies in Aarhus in the summer of 2010. He received his BS in February 2014. In his final year of obtaining his medical degree, he took a one year break from his studies, coming to the center for resuscitation science in an international research fellowship with Aarhus University, Denmark. The collaboration with the Danish medical universities has been in effect for several years, and their successful work captivated him to get involved in this program. During his research year here in Boston, Mathias has been leading a database project in acute respiratory compromise, a review on biomarkers in cardiac arrest, and the use of a novel biomarker in cardiac surgery, as well as being involved in several other projects. In September, Mathias will be returning to Denmark, to finish Medical School by February 2018, in hopes of returning to center for resuscitation science for a PhD degree, following in the footsteps of his supervisor Lars Andersen.

Latest Publications

  • Moskowitz A, Andersen LW, Cocchi MN, Karlsson M, Patel PV, Donnino MW. Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial. Annals of the American Thoracic Society. (2016) 0thser. 0.0
  • Moskowitz A, Andersen LW, Karlsson M, Grossestreuer AV, Chase M, Cocchi MN, Berg K, Donnino MW. Predicting In-Hospital Mortality for Initial Survivors of Acute Respiratory Compromise (ARC) events: Development and Validation of the ARC Score. Resuscitation. (2016) 0thser. 0.0

Steen Fagerberg, MD

About Steen Fagerberg

Steen is a medical doctor from Denmark, currently enrolled as a pre-doctorate research fellow from Aarhus University, Denmark, under the Supervision of Dr. Mike Donnino. Steen received his BS in Science in 2010 and his MD in 2015, and finalized his PhD this winter, under the supervision of Prof. Helle A Praetorius. Steen is at the Center for Resuscitation Science in an international research fellowship with Aarhus University, Denmark, from may until August 2016, Denmark. As a step in creating a link between basic sciences and clinical sciences, Steen is taking a physiological approach to the blood cells from septic patients, to investigate the clinical relevance of an ATP activated volume regulator, which seems to be a limiting step in the development of lysis. Throughout a series of in vitro and in vivo animal experiment he has been investigating purinergic receptors (P2X) and their importance for cell’s own defense against bacterial pore formers such as Alpha-Hemolysin from E. coli or Alpha-toxin from S. Aureus, as well as these receptors role in the initial cell signaling following bacterial infections. The Center of Resuscitation Science provides an ideal opportunity to work with highly clinical questions at the bench.

Tatsuma Fukuda, MD

About Tatsuma Fukuda

Dr. Tatsuma Fukuda is a Research Fellow in the Department of Emergency Medicine at Beth Israel Deaconess Medical Center. Dr. Fukuda graduated with a Ph.D. in Emergency and Critical Care Medicine from the University of Tokyo in 2016. Additionally, he holds a Doctorate in Medicine from Kochi Medical School in Japan, which he received in 2007. Dr. Fukuda’s research interests include health service research, primarily in out-of-hospital cardiac arrest. He is currently investigating the association of prehospital care with outcomes after out-of-hospital cardiac arrest, using “big data” from large cardiac arrest registries. Dr. Fukuda’s research won the 2016 JRC Okada Award from the Japan Resuscitation Council and the 2016 Petter Steen Young Investigator Award from the European Resuscitation Council.

Alexander Wulff, MS

About Alexander Wulff

Alex comes from California where he spent 2 years as the clinical research coordinator for a pediatric pulmonary specialty group focusing on cystic fibrosis, asthma, and bronchopulmonary dysplasia. After leaving California he obtained his Masters in Medical Science from Boston University School of Medicine where he published his thesis on genetic variability in fracture healing assessed through callus composition and strength. After graduation he followed his desire to do research in emergency medicine. He currently is the point research assistant on the Phase II clinical trial studying the effects of esmolol in septic shock, funded by the American Heart Association, with Dr. Cocchi. Alex is also involved with a project looking into septic bundle criteria and adherence of the bundle in the emergency and intensive care units with Dr. Cocchi.

Christopher Sulmonte, BS

About Christopher Sulmonte

Chris is originally from Abington, Massachusetts. He completed his undergraduate degree in Chemistry at Boston College in 2014. During this time, Chris worked in the Center for Resuscitation Science Internship program for two and half years. Following graduation, Chris joined the team full time as a research assistant, for which he has continued for the last two years. Now, as senior RA, Chris has taken on multiple responsibilities in the day to day operations of Center including Internship Coordinator. He is also the point research assistant on two Phase II clinical trials, one studying the effects of atorvastatin treatment on influenza with Dr. Chase and the other studying the treatment of thiamine for intubated populations with Dr. Berg. Chris has also been involved with many abstract publications in the last two years including a study of Cytochrome c levels in Septic Shock patients as well as a study looking at the association of severity of illness to Pyruvate dehydrogenase activity in patients with diabetic ketoacidosis. Finally, Chris has contributed to a multitude of different Quality Assurance initiatives happening at Beth Israel Deaconess Medical Center specifically in areas relating to rapid in hospital first aid and code blue response. This fall, Chris will be heading to Johns Hopkins University’s Bloomberg School of Public Health to purse a Master Degree in Healthcare Administration to be completed in May 2018.